GlybatomaqTM312317b:Novel Series of Quantum Thinking Ligands targeted
A Quantum Entropy and Special AI in practicePart II
(Sprache: Englisch)
GlybatomaqTM312317b: Ab initio Systematic Parameterization of Polarizable Force Field Quantum Chemistry mechanics-based free energy perturbation methodologies for calculating relative solvation free energies of a Novel Series of Quantum Thinking Ligands...
Leider schon ausverkauft
versandkostenfrei
Buch
129.90 €
Produktdetails
Produktinformationen zu „GlybatomaqTM312317b:Novel Series of Quantum Thinking Ligands targeted “
Klappentext zu „GlybatomaqTM312317b:Novel Series of Quantum Thinking Ligands targeted “
GlybatomaqTM312317b: Ab initio Systematic Parameterization of Polarizable Force Field Quantum Chemistry mechanics-based free energy perturbation methodologies for calculating relative solvation free energies of a Novel Series of Quantum Thinking Ligands targeted to the ETS1, PTPRZ, CASP8AP2 and FAS, EPTP-ADAM22 Tudor domain of human PHF20-mediated Glioma and Glioblastoma cell apoptosis with Rb tumor suppressor agonistic properties; A Quantum Entropy and Special AI in practice.
Autoren-Porträt von ioannis Grigoriadis
Grigoriadis, ioannisGrigoriadis G. Ioannis has completed his PharmacistD at the age of 24 years from the Aristotle University of Thessaloniki School of Pharmacy. He has published more than 379 papers and He is the Chairman of the WAMS International Board for Pharmaceutical Biotechnology and Clinical Pharmacy and the scientific director of Biogenea Pharma
Bibliographische Angaben
- Autor: ioannis Grigoriadis
- 2019, 652 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: Scholar's Press
- ISBN-10: 6138919939
- ISBN-13: 9786138919933
Sprache:
Englisch
Kommentar zu "GlybatomaqTM312317b:Novel Series of Quantum Thinking Ligands targeted"
0 Gebrauchte Artikel zu „GlybatomaqTM312317b:Novel Series of Quantum Thinking Ligands targeted“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "GlybatomaqTM312317b:Novel Series of Quantum Thinking Ligands targeted".
Kommentar verfassen